Biolegend, 565504, Biotinylated Recombinant Human FOLR1 (carrier-free)
25microg
Catalog Number: 565504
Send an RFQ.
Category
| Source | Human FOLR1, amino acid (Arg25-Met233) (Accession: # P15328) with a C-terminal 8His and Avi tag, was expressed in CHO cells. |
|---|---|
| Molecular Mass | The 246 amino acid recombinant protein has a predicted molecular mass of approximately 28.4 kD. The DTT-reduced and non-reduced protein migrates at approximately 35-45 kD and 35-40 kD respectively as determined by SDS-PAGE. The predicted N-terminal amino acid is Arg. |
| Purity | > 95%, as determined by Coomassie stained SDS-PAGE. |
| Formulation | 0.22 µm filtered protein solution is in PBS, pH 7.2 |
| Endotoxin Level | Less than 0.1 EU per µg cytokine as determined by the LAL method. |
| Concentration | 25 µg size is bottled at 200 µg/mL. 100 µg size and larger sizes are lot-specific and bottled at the concentration indicated on the vial. To obtain lot-specific concentration and expiration, please enter the lot number in our Certificate of Analysis online tool. |
| Storage & Handling | Unopened vial can be stored between 2°C and 8°C for up to 2 weeks, at -20°C for up to six months, or at -70°C or colder until the expiration date. For maximum results, quick spin vial prior to opening. The protein can be aliquoted and stored at -20°C or colder. Stock solutions can also be prepared at 50 - 100 µg/mL in appropriate sterile buffer, carrier protein such as 0.2 - 1% BSA or HSA can be added when preparing the stock solution. Aliquots can be stored between 2°C and 8°C for up to one week and stored at - 20°C or colder for up to 3 months. Avoid repeated freeze/thaw cycles. |
Unless otherwise stated, the minimum order amount is USD 1,000.
For orders below USD 1,000, an additional handling fee may apply, or we may arrange local delivery / local handover where available.
All quotations are subject to final confirmation, including product availability, lead time, batch information, shipping cost, and applicable export or handling requirements.
For quotation requests, please send an RFQ from website or contact:
Please send inquiries directly to us in the “To” field. Emails sent via BCC, mass mailing, or with unrelated recipients may be automatically filtered and will not be processed.
| Activity | Biotinylated Recombinant Human FOLR1 binds to immobilized FA-BSA (folic acid BSA conjugate). The EC50 of this effect is 0.5 – 3.0 ng/mL. |
|---|
| Application | Bioassay |
|---|
| Application Notes | BioLegend carrier-free recombinant proteins provided in liquid format are shipped on blue-ice. Our comparison testing data indicates that when handled and stored as recommended, the liquid format has equal or better stability and shelf-life compared to commercially available lyophilized proteins after reconstitution. Our liquid proteins are validated in-house to maintain activity after shipping on blue ice and are backed by our 100% satisfaction guarantee. If you have any concerns, contact us at [email protected]. |
|---|
| Structure | GPI-anchored N-glycosylated |
|---|
| Distribution | Plasma membrane, GPI-anchored, ER membrane, endosome, limited expression on the apical surfaces of the epithelial cells of normal lung, breast, thyroid, parathyroid, and kidney tissues |
|---|
| Function | Folate receptor (FOLR1) binds to folate and reduced folic acid derivatives and mediates delivery of 5-methyltetrahydrofolate and folate analogs into the interior of cells. It is required for embryonic development and cell proliferation. |
|---|
| Ligand/Receptor | Folate and folic acid derivatives |
|---|
| Bioactivity | Biotinylated Recombinant Human FOLR1 binds to immobilized FA-BSA (folic acid BSA conjugate). The EC50 of this effect is 0.5 – 3.0 ng/mL. |
|---|
| Biology Area | Cell Biology, Cell Proliferation and Viability, Signal Transduction |
|---|
| Molecular Family | Carrier Proteins |
|---|
| Antigen References | Luhrs CA & Slomiany BL. 1989. J Biol Chem. 264:21446-9. Sierra EEP & Goldman ID. 1999. Semin Oncol. 26:11-23. Cheung A, et al. 2018. Clin Cancer Res. 24:5098-111. Cheung A, et al. 2016. Oncotarget. 7:52553–74. Kelemen LE. 2006. Int J Cancer. 119:243-50. Spannuth WA, et al. 2010. Expert Opin Biol Ther. 10:431-437. Kelemen LE, et al. 2004. Cancer Causes Control. 15:1085-93. Kelemen LE, et al. 2008. Cancer Res. 68:2498-506. Liu JJ, et al. 2010. Adv Genet. 71:79-121. Kotsopoulos J, et al. 2010. Int J Cancer. 126:2191-2198. Nawab FN and Kipreos ET. 2022. Trends Endocrinol Metab. 33:159-174. Piedrahita JA, et al. 1999. Nat. Genet. 23:228. |
|---|
| Gene ID | 2348 |
|---|
| UniProt | View information about FOLR1 on UniProt.org |
|---|
| Regulatory Status | RUO |
|---|
| Other Names | Adult folate-binding protein (FBP), Folate receptor 1, Folate receptor, adult KB cells FBP, Ovarian tumor-associated antigen MOv18 |
|---|